Hon CHRIS HIPKINS: No, not at this point. Our goal is to ensure that everybody who can have a vaccine—and at this point, that's the adult population—has access to a vaccine and gets a vaccine. We're working hard to ensure that they have good information so that when they are offered a vaccine, they take it. Our tier 1 vaccine experience indicates that the take-up rate is very high—well over 95 percent at this point. If we continue to get that kind of take-up as we move through the rest of the sequencing framework, we'll be very, very happy.